Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The histamine H3-receptor: a target for developing new drugs.

× No keyword cloud information.

13 in total

1. Cardiovascular effects of the novel histamine H2 receptor agonist amthamine: interaction with the adrenergic system.

Authors: G Coruzzi; E Gambarelli; G Bertaccini; H Timmerman
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-03 Impact factor: 3.000

2. The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.

Authors: E Schlicker; I Marr
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-02 Impact factor: 3.000

Review 3. An update on histamine H3 receptors and gastrointestinal functions.

Authors: G Bertaccini; G Coruzzi
Journal: Dig Dis Sci Date: 1995-09 Impact factor: 3.199

Review 4. Design of histamine H3-receptor agonists and antagonists.

Authors: W Schunack; H Stark
Journal: Eur J Drug Metab Pharmacokinet Date: 1994 Jul-Sep Impact factor: 2.441

5. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?

Authors: E Schlicker; M Kathmann; H Bitschnau; I Marr; S Reidemeister; H Stark; W Schunack
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-04 Impact factor: 3.000

6. Histamine and Seizures : Implications for the Treatment of Epilepsy.

Authors: H Yokoyama; K Iinuma
Journal: CNS Drugs Date: 1996-05 Impact factor: 5.749

7. Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.

Authors: M Kathmann; E Schlicker; M Göthert
Journal: Psychopharmacology (Berl) Date: 1994-12 Impact factor: 4.530

8. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.

Authors: R Leurs; M T Tulp; W M Menge; M J Adolfs; O P Zuiderveld; H Timmerman
Journal: Br J Pharmacol Date: 1995-10 Impact factor: 8.739

9. H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase.

Authors: E Schlicker; M Kathmann; M Detzner; H J Exner; M Göthert
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1994-07 Impact factor: 3.000

10. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.

Authors: F P Jansen; T S Wu; H P Voss; H W Steinbusch; R C Vollinga; B Rademaker; A Bast; H Timmerman
Journal: Br J Pharmacol Date: 1994-10 Impact factor: 8.739